These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4692646)

  • 1. Allylisopropylacetamide-induced propyria-protective effect of 3,5-dimethylisooxazole.
    Pinelli A; Favalli L
    Biochem Pharmacol; 1973 Apr; 22(7):797-801. PubMed ID: 4692646
    [No Abstract]   [Full Text] [Related]  

  • 2. Drugs affecting porphyrin and lipid metabolism in rats: effects exerted by allylisopropylacetamide and related molecules.
    Pinelli A; Colombo R; Manitto P; Monti D
    Pharmacology; 1981; 22(6):337-42. PubMed ID: 7267699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemically induced porphyria: protection by treatment with nicotinic acid.
    Pinelli A; Favalli L
    Eur J Pharmacol; 1972 Oct; 20(1):136-8. PubMed ID: 4344424
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of DL-propranolol on delta-aminolevulinic acid synthetase activity and urinary excretion of porphyrins in allylisopropylacetamide-induced experimental porphyria.
    Blum I; Schoenfeld N; Atsmon A
    Biochim Biophys Acta; 1973 Sep; 320(2):242-8. PubMed ID: 4750745
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiporphyric activity of thiophene-2-carboxylic acid in allylisopropylacetamide-treated rats.
    Pinelli A; Capuano A; Bellei M
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 279(2):203-6. PubMed ID: 4272458
    [No Abstract]   [Full Text] [Related]  

  • 6. Antiporphyric activity of 3,5-dimethylpyrazole in allylisopropylacetamide-treated rats.
    Pinelli A; Favalli L; Formento M
    Life Sci II; 1973 Feb; 12(3):117-25. PubMed ID: 4708199
    [No Abstract]   [Full Text] [Related]  

  • 7. Experimental porphyria. II. Drug-induced porphyrin biosynthesis.
    Creighton JM; Racz WJ; Tyrrell DL; Schneck DW; Marks GS
    S Afr Med J; 1971 Sep; ():79-81. PubMed ID: 5150298
    [No Abstract]   [Full Text] [Related]  

  • 8. Antilipaemic and antiporphyric activity of nicotinic acid in allylisopropylacetamide-treated rats.
    Pinelli A; Favalli L
    Biochim Biophys Acta; 1972 Sep; 279(2):316-9. PubMed ID: 5082502
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug induced porphyrin biosynthesis. IX. Levels of 14C-allylisopropylacetamide, 14C-propylisopropylacetamide and metabolite(s) in the livers of chick embryos and mice.
    Krupa V; Blattel RA; Marks GS
    Enzyme; 1973; 16(1):276-85. PubMed ID: 4791048
    [No Abstract]   [Full Text] [Related]  

  • 10. Porphyrin synthesis in drug induced hepatic porphyria.
    Rao MR; Padmanaban G; Sarma PS
    Biochem Pharmacol; 1971 Aug; 20(8):2001-7. PubMed ID: 5137957
    [No Abstract]   [Full Text] [Related]  

  • 11. Drug-induced porphyrin biosynthesis-XI. Effect of SKF 525-A on the activity of porphyrin-inducing drugs in chick embryos, chickens and rats.
    Taub H; Krupa V; Marks GS
    Biochem Pharmacol; 1976 Mar; 25(5):511-6. PubMed ID: 942487
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced porphyrin biosynthesis. 8. Investigation of the importance of an allyl group for activity in substituted acetamides.
    Marks GS; Krupa V; Roomi MW
    Can J Physiol Pharmacol; 1973 Nov; 51(11):863-8. PubMed ID: 4762434
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug-induced porphyrin biosynthesis--XVI. Effects of hydrocortisone, adenosine 3':5'-cyclic monophosphoric acid, its dibutyryl derivative and a phosphodiesterase inhibitor on allylisopropylacetamide-induced porphyrin biosynthesis in chick embryo liver cells maintained in serum-free Waymouth medium.
    Morgan RO; Stephens JK; Fischer PW; Marks GS
    Biochem Pharmacol; 1977 Aug; 26(15):1389-94. PubMed ID: 197964
    [No Abstract]   [Full Text] [Related]  

  • 14. Decreased levels of cytochrome P-450 and catalase in hepatic porphyria caused by substituted acetamides and barbiturates. Importance of the allyl group in the molecule of the active drugs.
    Abbritti G; De Matteis F
    Chem Biol Interact; 1972 Mar; 4(4):281-6. PubMed ID: 5008942
    [No Abstract]   [Full Text] [Related]  

  • 15. delta-aminolevulinic acid synthetase from the particulate fraction of liver of porphyric rats.
    Kaplan BH
    Biochim Biophys Acta; 1971 May; 235(2):381-8. PubMed ID: 5317642
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of decreased oxygen pressure in the inspired air on the biosynthesis of prophyrins in the rat with experimental porphyria].
    Gajdos A; Gajdos-Török M; Strumza MV
    C R Seances Soc Biol Fil; 1969; 163(6):1343-6. PubMed ID: 4259290
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiporphyric activity of theophylline in normal and allylisopropylacetaminde-treated rats.
    Pinelli A; Capuano A; Maestri P
    Biochem Pharmacol; 1978; 27(13):1729-30. PubMed ID: 708453
    [No Abstract]   [Full Text] [Related]  

  • 18. The effects of haem arginate and haematin upon the allylisopropylacetamide induced experimental porphyria in rats.
    Tokola O; Lindén IB; Tenhunen R
    Pharmacol Toxicol; 1987 Jul; 61(1):75-8. PubMed ID: 3628186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interactions in experimental hepatic porphyria. A model for the exacerbation by drugs of human variegate porphyria.
    De Matteis F
    Enzyme; 1973; 16(1):266-75. PubMed ID: 4791047
    [No Abstract]   [Full Text] [Related]  

  • 20. Experimental porphyria. I. The experimental porphyrias--a group of distinctive metabolic lesions.
    Sweeney GD; Janigan D; Mayman D; Lai H
    S Afr Med J; 1971 Sep; ():68-72. PubMed ID: 4113777
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.